Non-coding RNAs in human disease

Nature Reviews Genetics

Volumn 12, Issue 12, 2011, Pages 861-874

  Esteller, Manel ^a,b,c  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MICRORNA; PIWI INTERACTING RNA; PROTEIN P53; SMALL NUCLEOLAR RNA; UNTRANSLATED RNA;

ANIMAL MODEL; ATHEROMATOSIS; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CPG ISLAND; CROHN DISEASE; DEVELOPMENTAL DISORDER; DRUG EFFICACY; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HEART ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HUMAN; HYPERTENSION; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; NEOPLASM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; RETT SYNDROME; REVIEW; SPINOCEREBELLAR DEGENERATION;

CARDIOVASCULAR DISEASES; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; NERVOUS SYSTEM DISEASES; RNA, UNTRANSLATED;

EID: 81355142141     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg3074     Document Type: Review

References (148)

1. Alexander, R. P., Fang, G., Rozowsky, J., Snyder, M. & Gerstein, M. B. Annotating non-coding regions of the genome. Nature Rev. Genet. 11, 559-571 (2010).
2. Mercer, T. R., Dinger, M. E. & Mattick, J. S. Long non-coding RNAs insight into functions. Nature Rev. Genet. 10, 155-159 (2009).
3. He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nature Rev. Genet. 5, 522-531 (2004).
4. Mendell, J. T. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 4, 1179-1184 (2005).
5. Esquela-Kerscher, A. & Slack, F. J. OncomiRs - microRNAs with a role in cancer. Nature Rev. Cancer 6, 259-269 (2006).
6. Hammond, S. M. MicroRNAs as tumor suppressors. Nature Genet. 39, 582-583 (2007).
7. Croce, C. M. Causes and consequences of microRNA dysregulation in cancer. Nature Rev. Genet. 10, 704-714 (2009).
8. Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S. & Calin. G. A. MicroRNAs - the micro steering wheel of tumour metastases. Nature Rev. Cancer 9, 293-302 (2009).
9. Carninci, P. et al. The transcriptional landscape of the mammalian genome. Science 309, 1559-1563 (2005).
10. Kapranov, P. et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316, 1484-1488 (2007).
11. Krol, J., Loedige, I. & Filipowicz, W. The widespread regulation of microRNA biogenesis, function and decay. Nature Rev. Genet. 11, 597-610 (2010).
12. Czech, B. & Hannon, G. J. Small RNA sorting: matchmaking for Argonautes. Nature Rev. Genet. 12, 19-31 (2011).
13. Aravin, A. A., Sachidanandam, R., Girard, A., Fejes-Toth, K. & Hannon, G. J. Developmentally regulated piRNA clusters implicate MILI in transposon control. Science 316, 744-747 (2007).
14. Brennecke, J. et al. Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell 128, 1089-1103 (2007).
15. Gunawardane, L. S. et al. A slicer-mediated mechanism for repeat-associated siRNA 5′ end formation in Drosophila. Science 315, 1587-1590 (2007).
16. Pal-Bhadra, M. et al. Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery. Science 303, 669-672 (2004).
17. Carmell, M. A. et al. MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev. Cell 12, 503-514 (2007).
18. Kuramochi-Miyagawa, S. et al. MVH in piRNA processing and gene silencing of retrotransposons. Genes Dev. 24, 887-892 (2010).
19. Watanabe, T. et al. Role for piRNAs and noncoding RNA in de novo DNA methylation of the imprinted mouse Rasgrf1 locus. Science 332, 848-852 (2011).
20. Kiss-László, Z., Henry, Y., Bachellerie, J. P., Caizergues-Ferrer, M. & Kiss, T. Site-specific ribose methylation of preribosomal RNA: a novel function for small nucleolar RNAs. Cell 85, 1077-1088 (1996).
21. Ni, J., Tien, A. L. & Fournier, M. J. Small nucleolar RNAs direct site-specific synthesis of pseudouridine in ribosomal RNA. Cell 89, 565-573 (1997).
22. King, T. H., Liu, B., McCully, R. R. & Fournier, M. J. Ribosome structure and activity are altered in cells lacking snoRNPs that form pseudouridines in the peptidyl transferase center. Mol. Cell 11, 425-435 (2003).
23. Navarro, P., Page, D. R., Avner, P. & Rougeulle, C. Tsix-mediated epigenetic switch of a CTCF-flanked region of the Xist promoter determines the Xist transcription program. Genes Dev. 20, 2787-2792 (2006).
24. Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).
25. Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323 (2007).
26. Plath. K. et al. Role of histone H3 lysine 27 methylation in X inactivation. Science 300, 131-135 (2003).
27. Guttman, M., Amit, I., Garber, M., French, C. & Lin, M. F. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223-227 (2009).
28. Huarte, M. et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419 (2010).
29. Guttman, M. et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295-300 (2011).
30. Orom, U. A., Derrien, T., Guigo, R. & Shiekhattar, R. Long noncoding RNAs as enhancers of gene expression. Cold Spring Harb. Symp. Quant. Biol. 75, 325-331 (2010).
31. Bejerano, G. et al. Ultraconserved elements in the human genome. Science 304, 1321-1325 (2004).
32. Bejerano, G. et al. A distal enhancer and an ultraconserved exon are derived from a novel retroposon. Nature 441, 87-90 (2006).
33. Calin, G. A. et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12, 215-229 (2007).
34. Lujambio, A. et al. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 29, 6390-6401 (2010).
35. Seila, A. C. et al. Divergent transcription from active promoters. Science 322, 1849-1851 (2008).
36. Preker, P. et al. RNA exosome depletion reveals transcription upstream of active human promoters. Science 322, 1851-1854 (2008).
37. Taft, R. J. et al. Tiny RNAs associated with transcription start sites in animals. Nature Genet. 41, 572-578 (2009).
38. Feuerhahn, S., Iglesias, N., Panza, A., Porro, A. & Lingner, J. TERRA biogenesis, turnover and implications for function. FEBS Lett. 584, 3812-3818 (2010).
39. Davalos, V. et al. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 29 Aug 2011 (10.1038/onc.2011.383).
40. Calin, G. A. et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99, 15524-15529 (2002).
41. Calin, G. A. et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA 101, 2999-3004 (2004).
42. Zhang, L. et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl Acad. Sci. USA 103, 9136-9141 (2006).
43. Melo, S. A. et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nature Genetics 41, 365-370 (2009).
44. Hill, D. A. et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 325, 965 (2009).
45. Melo, S. A. et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18, 303-315 (2010).
46. Lu, Y. et al. Identification of piRNAs in HeLa cells by massive parallel sequencing. BMB Rep. 43, 635-641 (2010).
47. Park, C. W., Zeng, Y., Zhang, X., Subramanian, S. & Steer, C. J. Mature microRNAs identified in highly purified nuclei from HCT116 colon cancer cells. RNA Biol. 7, 606-614 (2010).
48. Cichocki, F. et al. Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-like RNA in human NK cells. J. Immunol. 185, 2009-2012 (2010).
49. Yan, Z. et al. Widespread expression of piRNA-like molecules in somatic tissues. Nucleic Acids Res. 39, 6596-6607 (2011).
50. Taubert, H. et al. Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. Oncogene 26, 1098-1100 (2007).
51. Sun, G. et al. Clinical significance of Hiwi gene expression in gliomas. Brain Res. 1373, 183-188 (2011).
52. Lee, J. H. et al. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum. Mol. Genet. 15, 201-211 (2006).
53. Liu, J. J. et al. Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int. J. Clin. Exp. Pathol. 3, 328-337 (2010).
54. Liu, X. et al. Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells. Int. J. Cancer 118, 1922-1929 (2006).
55. Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G. & Levine, S. S. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125, 301-313 (2006).
56. Janic, A., Mendizabal, L., Llamazares, S., Rossell, D. & Gonzalez, C. Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila. Science 330, 1824-1827 (2010).
57. + stem cells express the hiwi gene, a human homologue of the Drosophila gene piwi. Blood 97, 426-434 (2001).
58. Chen, L. et al. Precancerous stem cells have the potential for both benign and malignant differentiation. PLoS ONE 2, e293 (2007).
59. Wang, Q., Han, C., Milum, K. & Wani, A. A. Stem cell protein Piwil2 modulates chromatin modifications upon cisplatin treatment. Mutat. Res. 708, 59-68 (2011).
60. Cheng, J. et al. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin. Chim. Acta 412, 1621-1625 (2011).
61. Chang, L. S., Lin, S. Y., Lieu, A. S. & Wu, T. L. Differential expression of human 5S snoRNA genes. Biochem. Biophys. Res. Commun. 299, 196-200 (2002).
62. Liao, J., Yu, L., Mei, Y., Guarnera, M. & Shen, J. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol. Cancer 9, 198 (2010).
63. Dong, X. Y., Guo, P., Boyd, J., Sun, X. & Li, Q. Implication of snoRNA U50 in human breast cancer. J. Genet. Genomics 36, 447-454 (2009).
64. Dong, X. Y. et al. snoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum. Mol. Genet. 17, 1031-1042 (2008).
65. Mourtada-Maarabouni, M., Hedge, V. L., Kirkham, L., Farzaneh, F. & Williams, G. T. Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5). J. Cell Sci. 121, 939-946 (2008).
66. Mourtada-Maarabouni, M., Pickard, M. R., Hedge, V. L., Farzaneh, F. & Williams, G. T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28, 195-208 (2009).
67. Bachellerie, J. P., Cavaillé, J. & Hüttenhofer, A. The expanding snoRNA world. Biochimie 84, 775-790 (2002).
68. Gupta, V. & Kumar, A. Dyskeratosis congenita. Adv. Exp. Med. Biol. 685, 215-219 (2010).
69. Scott, M. S. & Ono, M. From snoRNA to miRNA: dual function regulatory non-coding RNAs. Biochimie 93, 1987-1992 (2011).
70. Rossi, S., Sevignani, C., Nnadi, S. C., Siracusa, L. D. & Calin, G. A. Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications. Mamm. Genome 19, 526-540 (2008).
71. Scaruffi, P. et al. Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma. BMC Cancer 9, 441 (2009).
72. Wojcik, S. E. et al. Non-coding RNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. Carcinogenesis 31, 208-215 (2010).
73. Braconi, C. et al. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc. Natl Acad. Sci. USA 108, 786-791 (2011).
74. Yu, W. et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451, 202-206 (2010).
75. Cao, X., Yeo, G., Muotri, A. R., Kuwabara, T. & Gage, F. H. Noncoding RNAs in the mammalian central nervous system. Annu. Rev. Neurosci. 29, 77-103 (2006).
76. Kim, J. et al. A microRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220-1224 (2007).
77. Schaefer, A. et al. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 204, 1553-1558 (2007).
78. Shin, D., Shin, J. Y., McManus, M. T., Ptácek, L. J. & Fu, Y. H. Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann. Neurol. 66, 843-857 (2009).
79. Hébert, S. S. et al. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum. Mol. Genet. 19, 3959-3969 (2010).
80. Ling, S. C, Albuquerque, C. P., Han, J. S., Lagier-Tourenne, C. & Tokunaga, S. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl Acad. Sci. USA 107, 13318-13323 (2010).
81. Edbauer, D., Neilson, J. R., Foster, K. A., Wang, C. F. & Seeburg, D. P. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65, 373-384 (2010).
82. Gehrke, S. et al. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466, 637-641 (2010).
83. Kuhn, D. E., Nuovo, G. J., Terry, A. V. Jr, Martin, M. M. & Malana, G. E. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. J. Biol. Chem. 285, 1529-1543 (2010).
84. Glinsky, G. V. An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway. Cell Cycle 7, 2570-2583 (2008).
85. Wang, G., van der Walt, J. M., Mayhew, G., Li, Y. J. & Z?chner, S. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of a-synuclein. Am. J. Hum. Genet. 82, 283-289 (2008).
86. Williams, A. H. et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326, 1549-1554 (2009).
87. Haramati, S. et al. miRNA malfunction causes spinal motor neuron disease. Proc. Natl Acad. Sci. USA 107, 13111-13116 (2010).
88. Lee, Y. et al. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nature Neurosci. 11, 1137-1139 (2008).
89. Hbert, S. S., Horr, K., Nicola, L., Papadopoulou, A. S. & Mandemakers, W. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression. Proc. Natl Acad. Sci. USA 105, 6415-6420 (2008).
90. Wang, W. X., Rajeev, B. W., Stromberg, A. J., Ren, N. & Tang, G. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of b-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28, 1213-1223 (2008).
91. Boissonneault, V., Plante, I., Rivest, S. & Provost, P. MicroRNA-298 and microRNA-328 regulate expression of mouse β-amyloid precursor protein-converting enzyme 1. J. Biol. Chem. 284, 1971-1981 (2009).
92. De Santis, G., Ferracin, M., Biondani, A., Caniatti, L. & Rosaria Tola, M. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J. Neuroimmunol. 226, 165-171 (2010).
93. Cox, M. B., Cairns, M. J., Gandhi, K. S., Carroll, A. P. & Moscovis, S. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS ONE 5, e12132 (2010).
94. Junn, E., Lee, K. W., Jeong, B. S., Chan, T. W. & Im, J. Y. Repression of a-synuclein expression and toxicity by microRNA-7. Proc. Natl Acad. Sci. USA 106, 13052-13057 (2009).
95. Chen, W. L., Lin, J. W. & Huang, H. J. SCA8 mRNA expression suggests an antisense regulation of KLHL1 and correlates to SCA8 pathology. Brain Res. 1233, 176-184 (2008).
96. Albinsson, S. et al. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler. Thromb. Vasc. Biol. 6, 1118-1126 (2010).
97. Zhao, Y. et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303-317 (2007).
98. Yang, B. et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nature Med. 13, 486-491 (2007).
99. Van Rooij, E. et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl Acad. Sci. USA 103, 18255-18260 (2006).
100. Fang, Y., Shi, C., Manduchi, E., Civelek, M. & Davies, P. F. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc. Natl Acad. Sci. USA 107, 13450-13455 (2010).
101. Cordes, K. R. et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460, 705-710 (2009).
102. Nicoli, S. et al. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 464, 1196-1200 (2010).
103. Ji, R. et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ. Res. 100, 1579-1588 (2007).
104. Clop, A. et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nature Genet. 38, 813-818 (2006).
105. Sethupathy, P. et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am. J. Hum. Genet. 81, 405-413 (2007).
106. Starczynowski, D. T. et al. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nature Med. 16, 49-58 (2010).
107. Gatto, S., Della Ragione, F., Cimmino, A., Strazzullo, M. & Fabbri, M. Epigenetic alteration of microRNAs in DNMT3B-mutated patients of ICF syndrome. Epigenetics 5, 427-443 (2010).
108. Urdinguio, R. G. et al. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 5, 656-663 (2010).
109. Wu, H. et al. Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA 107, 18161-18166 (2010).
110. Brest, P. et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nature Genet. 43, 242-245 (2011).
111. Lewis, M. A. et al. An ENU-induced mutation of miR-96 associated with progressive hearing loss in mice. Nature Genet. 41, 614-618 (2009).
112. Faghihi, M. A. et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nature Med. 14, 723-730 (2008).
113. Martínez, F. et al. Enrichment of ultraconserved elements among genomic imbalances causing mental delay and congenital anomalies. BMC Med. Genomics 3, 54 (2010).
114. Horsthemke, B. & Wagstaff, J. Mechanisms of imprinting of the Prader-Willi/Angelman region. Am. J. Med. Genet. A. 146 A, 2041-2052 (2008).
115. Kishore, S. & Stamm, S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 311, 230-232 (2006).
116. Sahoo, T. et al. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nature Genet. 40, 719-721 (2008).
117. Kuramochi-Miyagawa, S. et al. Mili, a mammalian member of piwi family gene, is essential for spermatogenesis. Development 131, 839-849 (2004).
118. Gu, A. et al. Genetic variants in Piwi-interacting RNA pathway genes confer susceptibility to spermatogenic failure in a Chinese population. Hum. Reprod. 25, 2955-2961 (2010).
119. Burd, C. E. et al. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet. 6, e1001233 (2010).
120. Stenvang, J., Lindow, M. & Kauppinen, S. Targeting of microRNAs for therapeutics. Biochem. Soc. Trans. 36, 1197-1200 (2008).
121. Krutzfeldt, J., Rajewsky, N. & Braich R. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689 (2005).
122. Elmen, J., Lindow, M. & Schutz, S. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899 (2008).
123. Esau, C. C. Inhibition of microRNA with antisense oligonucleotides. Methods 44, 55-60 (2008).
124. Ma, L. et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nature Biotech. 28, 341-347 (2010).
125. Lu, Y., Xiao, J. & Lin, H. A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Res. 37, e24 (2009).
126. Cohen, S. M. Use of microRNA sponges to explore tissue-specific microRNA functions in vivo. Nature Methods 6, 873-874 (2009).
127. Ma, L. et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nature Cell Biol. 12, 247-256 (2010).
128. Kota, J. et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017 (2009).
129. Kay, M. A. State-of-the-art gene-based therapies: the road ahead. Nature Rev. Genet. 12, 316-328 (2011).
130. Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R. & Jacks, T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nature Genet. 39, 673-677 (2007).
131. Shan, G. et al. A small molecule enhances RNA interference and promotes microRNA processing. Nature Biotech. 26, 933-940 (2008).
132. Melo, S. et al. The small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc. Natl Acad. Sci. USA 108, 4394-4399 (2011).
133. Saito, Y. et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435-443 (2006).
134. Lujambio, A. et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67, 1424-1429 (2007).
135. Rodríguez-Paredes, M. & Esteller, M. Cancer epigenetics reaches mainstream oncology. Nature Med. 17, 330-339 (2011).
136. Tsai, M. C. et al. Long noncoding RNA as a modular scaffold of histone modification complexes. Science 329, 689-693 (2010).
137. Tsai, M. C., Spitale, R. C. & Chang, H. Y. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 71, 3-7 (2011).
138. Lunse, C. E., Michlewski, G. & Hopp, C. S. An aptamer targeting the apical-loop domain modulates pri-miRNA processing. Angew. Chem. Int. Ed. Engl. 49, 4674-4677 (2010).
139. Costa, F. F. Non-coding RNAs and new opportunities for the private sector. Drug Discov. Today 14, 446-452 (2009).
140. The ENCODE Project Consortium. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816 (2007).
141. Ponjavic, J., Ponting, C. P. & Lunter, G. Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res. 17, 556-565 (2007).
142. Medina, P. P., Nolde, M. & Slack, F. J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90 (2010).
143. Voorhoeve, P. M. et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124, 1169-1181 (2006).
144. Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984 (2008).
145. Eggermann, T. Silver-Russell and Beckwith- Wiedemann syndromes: opposite (epi)mutations in 11p15 result in opposite clinical pictures. Horm. Res. 71, (Suppl. 2), 30-35 (2009).
146. Williamson, C. M. et al. Uncoupling antisense-mediated silencing and DNA methylation in the imprinted Gnas cluster. PLoS Genet. 7, e1001347 (2011).
147. Pauley, K. M. & Cha, S. miRNA-146a in rheumatoid arthritis: a new therapeutic strategy. Immunotherapy 3, 829-831 (2011).
148. Temple, I. K. & Shield, J. P. Transient neonatal diabetes, a disorder of imprinting. J. Med. Genet. 39, 872-875 (2002).